Ono Pharmaceutical Beheer
Beheer criteriumcontroles 3/4
Ono Pharmaceutical's CEO is Gyo Sagara, appointed in Sep 2008, has a tenure of 16.17 years. total yearly compensation is ¥190.00M, comprised of 41.1% salary and 58.9% bonuses, including company stock and options. directly owns 0.026% of the company’s shares, worth ¥234.98M. The average tenure of the management team and the board of directors is 1.8 years and 4.4 years respectively.
Belangrijke informatie
Gyo Sagara
Algemeen directeur
JP¥190.0m
Totale compensatie
Percentage CEO-salaris | 41.1% |
Dienstverband CEO | 16.2yrs |
Eigendom CEO | 0.03% |
Management gemiddelde ambtstermijn | 1.8yrs |
Gemiddelde ambtstermijn bestuur | 4.4yrs |
Recente managementupdates
Recent updates
Ono Pharmaceutical Co., Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Nov 03We Think Ono Pharmaceutical (TSE:4528) Can Stay On Top Of Its Debt
Aug 25Ono Pharmaceutical Co., Ltd. (TSE:4528) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 04There's No Escaping Ono Pharmaceutical Co., Ltd.'s (TSE:4528) Muted Earnings
Jun 24Ono Pharmaceutical (TSE:4528) Has Announced A Dividend Of ¥40.00
Mar 04Is There An Opportunity With Ono Pharmaceutical Co., Ltd.'s (TSE:4528) 42% Undervaluation?
Feb 27Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Sep 30 2024 | n/a | n/a | JP¥95b |
Jun 30 2024 | n/a | n/a | JP¥121b |
Mar 31 2024 | JP¥190m | JP¥78m | JP¥128b |
Dec 31 2023 | n/a | n/a | JP¥128b |
Sep 30 2023 | n/a | n/a | JP¥125b |
Jun 30 2023 | n/a | n/a | JP¥115b |
Mar 31 2023 | JP¥228m | JP¥77m | JP¥113b |
Compensatie versus markt: Gyo's total compensation ($USD1.24M) is about average for companies of similar size in the JP market ($USD1.08M).
Compensatie versus inkomsten: Gyo's compensation has been consistent with company performance over the past year.
CEO
Gyo Sagara (66 yo)
16.2yrs
Tenure
JP¥190,000,000
Compensatie
Mr. Gyo Sagara has been the Chief Executive Officer at Ono Pharmaceutical Co., Ltd since April 01, 2024 and serves as it’s Director and served as its President since September 2008 until April 01, 2024 and...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO & Chairman of the Board | 16.2yrs | JP¥190.00m | 0.026% ¥ 235.0m | |
President | less than a year | geen gegevens | 0.0092% ¥ 84.2m | |
Corp. Offcr. and Div. Dir. of Corp. Strategy & Planning | 1.3yrs | geen gegevens | geen gegevens | |
Corporate Officer & Head of Risk and Compliance Management Department | 1.8yrs | geen gegevens | geen gegevens | |
Managing Executive Officer | no data | geen gegevens | geen gegevens | |
Corporate Officer & Head of Business Strategy Headquarters | 1.8yrs | geen gegevens | geen gegevens | |
Ex. EO, Executive Dir. of Sus. Promotion Corp. Strategy & Planning and Representative Director | 1.8yrs | geen gegevens | 0.0060% ¥ 54.8m | |
Corporate Officer & Deputy Executive Director | no data | geen gegevens | geen gegevens | |
Corporate Officer & Head of Medical Affairs | no data | geen gegevens | geen gegevens | |
Managing Executive Officer & CMC / Production Division Chief | no data | geen gegevens | geen gegevens | |
Head of Development Div. | no data | geen gegevens | geen gegevens |
1.8yrs
Gemiddelde duur
60yo
Gemiddelde leeftijd
Ervaren management: 4528's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO & Chairman of the Board | 18.4yrs | JP¥190.00m | 0.026% ¥ 235.0m | |
President | 4.4yrs | geen gegevens | 0.0092% ¥ 84.2m | |
Ex. EO, Executive Dir. of Sus. Promotion Corp. Strategy & Planning and Representative Director | 4.4yrs | geen gegevens | 0.0060% ¥ 54.8m | |
Independent Outside Director | 3.4yrs | geen gegevens | geen gegevens | |
Outside Audit & Supervisory Board Member | 4.4yrs | geen gegevens | geen gegevens | |
Outside Audit & Supervisory Board Member | 8.4yrs | geen gegevens | geen gegevens | |
Audit & Supervisory Board Member | less than a year | geen gegevens | 0.0032% ¥ 29.3m | |
Independent Outside Director | 6.4yrs | geen gegevens | geen gegevens | |
Independent Outside Director | 4.4yrs | geen gegevens | geen gegevens | |
Chairman of Audit Supervisory Board | 3.4yrs | geen gegevens | 0.00043% ¥ 4.0m |
4.4yrs
Gemiddelde duur
60yo
Gemiddelde leeftijd
Ervaren bestuur: 4528's board of directors are considered experienced (4.4 years average tenure).